PAUL KLEIST

Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology MONROEVILLE, PA NPI 1013970185

General Payments — all program years on this page

$702.62

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 29
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $401.90 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $401.9017

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $143.229
SCPHARMACEUTICALS INC. $115.001
PFIZER INC. $66.263
Amgen Inc. $44.372
BOSTON SCIENTIFIC CORPORATION $33.052

By program year

Program yearAmountRecords
2018 $27.522
2019 $134.943
2020 $17.141
2022 $48.122
2023 $73.004
2024 $401.9017

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087127000 Novartis Pharmaceuticals Corporation $18.87 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087127006 Novartis Pharmaceuticals Corporation $11.00 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087127016 Novartis Pharmaceuticals Corporation $21.01 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087127022 Novartis Pharmaceuticals Corporation $9.87 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087127024 Novartis Pharmaceuticals Corporation $25.78 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087127028 Novartis Pharmaceuticals Corporation $11.14 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087127042 Novartis Pharmaceuticals Corporation $21.36 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087127044 Novartis Pharmaceuticals Corporation $20.80 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087127054 Novartis Pharmaceuticals Corporation $3.39 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092303537 Boston Scientific Corporation $13.15 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092303539 Boston Scientific Corporation $19.90 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115819418 Amgen Inc. $23.90 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117599916 Amgen Inc. $20.47 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131077833 PFIZER INC. $30.81 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131421252 PFIZER INC. $18.83 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132122924 PFIZER INC. $16.62 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132314510 SCPHARMACEUTICALS INC. $115.00 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.